The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells

被引：11

作者：

Dar, Javid A. ^{[1
,4
]}

Masoodi, Khalid Z. ^{[1
]}

Eisermann, Kurtis ^{[1
]}

Isharwal, Sudhir ^{[1
]}

Ai, Junkui ^{[1
]}

Pascal, Laura E. ^{[1
]}

Nelson, Joel B. ^{[1
,3
]}

Wang, Zhou ^{[1
,2
,3
]}

机构：

[1] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15232 USA

[2] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA

[3] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15232 USA

[4] King Saud Univ, Coll Sci, Cent Lab, Riyadh Ksa 11451, Saudi Arabia

来源：

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 2014年 / 143卷

基金：

美国国家卫生研究院;

关键词：

AMINO-ACID SUBSTITUTIONS; DNA-BINDING DOMAIN; TRANSCRIPTIONAL ACTIVATION; TRANSACTIVATION DOMAIN; INSENSITIVITY SYNDROME; COMPLEMENTARY-DNA; HSP90; INHIBITOR; LIGAND; MUTATION; IDENTIFICATION;

D O I：

10.1016/j.jsbmb.2014.03.004

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Androgen-independent nuclear localization is required for androgen receptor (AR) transactivation in castration-resistant prostate cancer (CRPC) and should be a key step leading to castration resistance. However, mechanism(s) leading to androgen-independent AR nuclear localization are poorly understood. Since the N-terminal domain (NTD) of AR plays a role in transactivation under androgen-depleted conditions, we investigated the role of the NTD in AR nuclear localization in CRPC. Deletion mutagenesis was used to identify amino acid sequences in the NTD essential for its androgen-independent nuclear localization in C4-2, a widely used CRPC cell line. Deletion mutants of AR tagged with green fluorescent protein (GFP) at the 5'-end were generated and their signal distribution was investigated in C4-2 cells by fluorescent microscopy. Our results showed that the region of a.a. 294-556 was required for androgen-independent AR nuclear localization whereas a.a. 1-293 mediates Hsp90 regulation of AR nuclear localization in CRPC cells. Although the region of a.a. 294-556 does not contain a nuclear import signal, it was able to enhance DHT-induced import of the ligand binding domain (LBD). Also, transactivation of the NTD could be uncoupled from its modulation of AR nuclear localization in C4-2 cells. These observations suggest an important role of the NTD in AR intracellular trafficking and androgen-independent AR nuclear localization in CRPC cells. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：473 / 480

页数：8

共 50 条

[31] Nuclear βArrestin1 regulates androgen receptor function in castration resistant prostate cancer [J].

Purayil, Hamsa Thayele ;

Zhang, Yushan ;

Black, Joseph B. ;

Gharaibeh, Raad ;

Daaka, Yehia .

ONCOGENE, 2021, 40 (14) :2610-2620

[32] Abiraterone Acetate: Targeting Persistent Androgen Dependence in Castration-Resistant Prostate Cancer [J].

Harshman, Lauren C. ;

Taplin, Mary-Ellen .

ADVANCES IN THERAPY, 2013, 30 (08) :727-747

[33] Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors [J].

Chen, Eddy J. ;

Sowalsky, Adam G. ;

Gao, Shuai ;

Cai, Changmeng ;

Voznesensky, Olga ;

Schaefer, Rachel ;

Loda, Massimo ;

True, Lawrence D. ;

Ye, Huihui ;

Troncoso, Patricia ;

Lis, Rosina L. ;

Kantoff, Philip W. ;

Montgomery, Robert B. ;

Nelson, Peter S. ;

Bubley, Glenn J. ;

Balk, Steven P. ;

Taplin, Mary-Ellen .

CLINICAL CANCER RESEARCH, 2015, 21 (06) :1273-1280

[34] EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor [J].

De Mol, Eva ;

Bryn Fenwick, R. ;

Phang, Christopher T. W. ;

Buzon, Victor ;

Szulc, Elzbieta ;

de la Fuente, Alex ;

Escobedo, Albert ;

Garcia, Jesus ;

Bertoncini, Carlos W. ;

Estebanez-Perpina, Eva ;

McEwan, Iain J. ;

Riera, Antoni ;

Salvatella, Xavier .

ACS CHEMICAL BIOLOGY, 2016, 11 (09) :2499-2505

[35] Ack1-mediated Androgen Receptor Phosphorylation Modulates Radiation Resistance in Castration-resistant Prostate Cancer [J].

Mahajan, Kiran ;

Coppola, Domenico ;

Rawal, Bhupendra ;

Chen, Y. Ann ;

Lawrence, Harshani R. ;

Engelman, Robert W. ;

Lawrence, Nicholas J. ;

Mahajan, Nupam P. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (26) :22112-22122

[36] Continued targeting of androgen receptor signalling: a rational and efficacious therapeutic strategy in metastatic castration-resistant prostate cancer [J].

Bianchini, Diletta ;

de Bono, Johann S. .

EUROPEAN JOURNAL OF CANCER, 2011, 47 :S189-S194

[37] Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer [J].

Guerrero, Javier ;

Alfaro, Ivan E. ;

Gomez, Francisco ;

Protter, Andrew A. ;

Bernales, Sebastian .

PROSTATE, 2013, 73 (12) :1291-1305

[38] Inhibition of Hedgehog and Androgen Receptor Signaling Pathways Produced Synergistic Suppression of Castration-Resistant Prostate Cancer Progression [J].

Gowda, Pramod S. ;

Deng, Jianhong D. ;

Mishra, Sweta ;

Bandyopadhyay, Abhik ;

Liang, Sitai ;

Lin, Shu ;

Mahalingam, Devalingam ;

Sun, Lu-Zhe .

MOLECULAR CANCER RESEARCH, 2013, 11 (11) :1448-1461

[39] Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage [J].

Li, Lei ;

Xie, Hongjun ;

Liang, Liang ;

Gao, Ye ;

Zhang, Dong ;

Fang, Leiya ;

Lee, Soo Ok ;

Luo, Jie ;

Chen, Xingfa ;

Wang, Xinyang ;

Chang, Luke S. ;

Yeh, Shuyuan ;

Wang, Yuzhuo ;

He, Dalin ;

Chang, Chawnshang .

CARCINOGENESIS, 2013, 34 (02) :257-267

[40] Targeting androgen receptor versus targeting androgens to suppress castration resistant prostate cancer [J].

Guo, Changcheng ;

Yeh, Shuyuan ;

Niu, Yuanjie ;

Li, Gonghui ;

Zheng, Junhua ;

Li, Lei ;

Chang, Chawnshang .

CANCER LETTERS, 2017, 397 :133-143

← 1 2 3 4 5 →